Can less pain meds mean better spinal stimulation? new study investigates

NCT ID NCT07502612

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study looks at how lowering doses of pain medications like opioids and gabapentinoids changes the way the spinal cord responds to closed-loop spinal cord stimulation. Twenty adults with failed back surgery syndrome will be followed during a 21-day trial and up to 6 months after a permanent implant. The goal is to understand the relationship between medication tapering and spinal cord sensitivity, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Closed-loop spinal cord stimulation (Evoke system)
What this could lead to
If successful, this study could help doctors understand how to safely reduce pain medication while using spinal cord stimulation to manage chronic back pain.
What could go wrong
This is a very small pilot study with only 20 participants, so results may not apply to everyone. It is designed to gather information, not to prove a treatment works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FAILED BACK SURGERY SYNDROME (FBSS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

complex regional pain syndrome type 2 Failed Back Surgery Syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Brai²n - ZAS Augustinus

    RECRUITING

    Wilrijk, 2610, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.